← Leaderboards
Henry F. Vanbrocklin
University Of California, San Francisco
$15,230,142
Attributed
$33,102,113
Total exposure
21
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $10.1M · FY2005–25$20M$15M$10M$5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$29,429,643 · 20
FDA$3,672,470 · 1
By mechanism
R01$16,977,394 · 8
U01$7,526,470 · 2
RM1$2,331,737 · 1
R44$2,000,000 · 1
R21$1,972,758 · 5
S10$1,277,085 · 1
Top collaborators
- John M Gerdes12 shared
- Timothy Jensen Henrich7 shared
- Charles Thompson7 shared
- Arkadij Elizarov6 shared
- Priscilla Y. Hsue5 shared
- Kurt R Zinn5 shared
- Rahul Aggarwal4 shared
- Robert Richard Flavell4 shared
Most similar at University Of California, San Francisco
Same institution · by research overlap
- Satya Dandekar$23,346,836
- Robert Richard Flavell$4,877,416
- Rahul Aggarwal$5,953,056
- Catherine Anne Stimets Koss$3,514,120
- Urvi M. Parikh$1,674,974
Others in their field
Top investigators on “Image”
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- David Heimbrook · Leidos Biomedical Research, Inc.$332,241,999
- Leonard Freedman · Leidos Biomedical Research, Inc.$321,574,964
- Charles Mattias Mountain · Association Of Universities For Research In Astronomy, Inc.$217,904,052
- Ethan Schreier · Associated Universities, Inc.$206,468,864
Research focus
ImagePositron-Emission TomographyTracerRadiotracerRadiolabeledTissuesIn VivoPharmaceutical PreparationsCohortInsightLabelCellsAlzheimer&AposMagnetic Resonance ImagingPeripheralProteinsUptakeProtocols DocumentationBaseReportingBloodLocationFirst-In-HumanNovel Strategies
Grant awards (50)
Multimodal PET-CT imaging of SIVmac239 dynamics post-ART interruption$3,302,677
R01 · FY2025 · AI
In Vivo Imaging and Post-Mortem Study of Methamphetamine Use on Immune Dysfunction and HIV Reservoir Transcription among People with HIV on ART$2,331,737
RM1 · FY2025 · DA
Improving availability of ImmunoPET via automation of radio-synthesis and quality control of antibody-based HIV imaging PET tracers on a single platform.$1,000,000
R44 · FY2025 · AI
First-in-Human evaluation of an astrocytic glutamate transporter (EAAT2) PET tracer in healthy and Alzheimer's diseased brain$804,521
R01 · FY2025 · AG
In Vivo PET Imaging of HIV Infection$735,024
R01 · FY2025 · AI
Systematic Testing of a TGFβ Targeted Theranostic in Preclinical Cancer$676,567
R01 · FY2025 · CA
Endovascular Filtration to Change Drug Biodistribution (ELOCUTION)$670,440
R01 · FY2025 · EB
Molecular imaging of novel PARP inhibitor nanomedicine delivery$621,383
R01 · FY2025 · CA · contact PI
Improving availability of ImmunoPET via automation of radio-synthesis and quality control of antibody-based HIV imaging PET tracers on a single platform.$1,000,000
R44 · FY2024 · AI
First-in-Human evaluation of an astrocytic glutamate transporter (EAAT2) PET tracer in healthy and Alzheimer's diseased brain$824,846
R01 · FY2024 · AG
In Vivo PET Imaging of HIV Infection$736,856
R01 · FY2024 · AI
Molecular imaging of novel PARP inhibitor nanomedicine delivery$590,313
R01 · FY2024 · CA · contact PI
First-in-Human evaluation of an astrocytic glutamate transporter (EAAT2) PET tracer in healthy and Alzheimer's diseased brain$816,825
R01 · FY2023 · AG
Molecular imaging of novel PARP inhibitor nanomedicine delivery$589,327
R01 · FY2023 · CA · contact PI
First-in-Human evaluation of an astrocytic glutamate transporter (EAAT2) PET tracer in healthy and Alzheimer's diseased brain$784,058
R01 · FY2022 · AG
In Vivo PET Imaging of HIV Infection$737,195
R01 · FY2022 · AI
Molecular imaging of novel PARP inhibitor nanomedicine delivery$576,944
R01 · FY2022 · CA · contact PI
Molecular Imaging of persistent HIV: CD30$282,625
R21 · FY2022 · AI · contact PI
In Vivo PET Imaging of HIV Infection$738,002
R01 · FY2021 · AI
Molecular Imaging of persistent HIV: CD30$161,500
R21 · FY2021 · AI · contact PI
In Vivo PET Imaging of HIV Infection$731,949
R01 · FY2020 · AI
Molecular Imaging of Chemical Threats and Countermeasures$802,585
U01 · FY2019 · NS
Improving availability of ImmunoPET via automation of radio-synthesis and quality control of antibody-based cancer imaging PET tracers on a single platform.$299,987
R43 · FY2019 · CA
Molecular Imaging of Chemical Threats and Countermeasures$804,973
U01 · FY2018 · NS
Astroglial EAAT2 Changes in Live TBI Brain Determined by PET Imaging$225,000
R41 · FY2018 · NS · contact PI
Mitigation of quality and compliance risks in radio-pharmaceutical production by implementation of an automated release testing technology.$913,280
U01 · FY2017 · FD
Molecular Imaging of Chemical Threats and Countermeasures$799,473
U01 · FY2017 · NS
Mitigation of quality and compliance risks in radio-pharmaceutical production by implementation of an automated release testing technology.$959,190
U01 · FY2016 · FD
Molecular Imaging of Chemical Threats and Countermeasures$717,099
U01 · FY2016 · NS
Mitigation of quality and compliance risks in radio-pharmaceutical production by implementation of an automated release testing technology.$1,800,000
U01 · FY2015 · FD
Molecular Imaging of Chemical Threats and Countermeasures$729,870
U01 · FY2015 · NS
In vivo reporters of gene expression$202,315
R21 · FY2015 · AI
In vivo reporters of gene expression$183,019
R21 · FY2014 · AI
PET and MR-Compatible Bioreactor for Cross-Platform Biomarker Development$153,162
R21 · FY2013 · CA · contact PI
PET and MR-Compatible Bioreactor for Cross-Platform Biomarker Development$135,533
R21 · FY2012 · CA · contact PI
In Vivo Pharmacokinetic and Pharmacodynamic Dispositions of Positron Radiolabeled$340,256
R21 · FY2011 · NS
In Vivo Pharmacokinetic and Pharmacodynamic Dispositions of Positron Radiolabeled$354,684
R21 · FY2010 · NS
MicroPET/CT for Small Animal Imaging$1,277,085
S10 · FY2007 · RR · contact PI
Evaluation of Iodorotenone, A SPECT Perfusion Tracer$587,244
R01 · FY2005 · EB
Targeted Molecular Probes for Tumor Imaging$201,579
R01 · FY2005 · CA
Targeted Molecular Probes for Tumor Imaging$194,327
R01 · FY2005 · CA
Evaluation of Iodorotenone, A SPECT Perfusion Tracer$516,391
R01 · FY2004 · EB
Targeted Molecular Probes for Tumor Imaging$386,313
R01 · FY2004 · CA
Targeted Molecular Probes for Tumor Imaging$393,383
R01 · FY2003 · CA
Evaluation of Iodorotenone, A SPECT Perfusion Tracer$389,093
R01 · FY2003 · EB
Targeted Molecular Probes for Tumor Imaging$372,137
R01 · FY2002 · CA
PET RADIOPHARMACEUTICALS FOR METABOLISM AND FLOW$90,462
P01 · FY2001 · HL
PET RADIOPHARMACEUTICALS FOR METABOLISM AND FLOW$200,610
P01 · FY2000 · HL
PET RADIOPHARMACEUTICALS FOR METABOLISM AND FLOW$200,610
P01 · FY2000 · HL
DEVELOPMENT OF CANCER IMAGING AGENTS$159,664
R21 · FY2000 · CA